Lifecore Biomedical, Inc. LDE.F Stock
Lifecore Biomedical, Inc. Price Chart
Lifecore Biomedical, Inc. LDE.F Financial and Trading Overview
Lifecore Biomedical, Inc. stock price | 5.4 EUR |
Previous Close | 7.85 EUR |
Open | 7.7 EUR |
Bid | 7.7 EUR x 100000 |
Ask | 7.95 EUR x 100000 |
Day's Range | 7.7 - 7.7 EUR |
52 Week Range | 1.54 - 11.3 EUR |
Volume | 40 EUR |
Avg. Volume | 0 EUR |
Market Cap | 233.48M EUR |
Beta (5Y Monthly) | 1.03169 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.97 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 14.4 EUR |
LDE.F Valuation Measures
Enterprise Value | 405.07M EUR |
Trailing P/E | N/A |
Forward P/E | 55 |
PEG Ratio (5 yr expected) | -35.17 |
Price/Sales (ttm) | 1.346534 |
Price/Book (mrq) | 6.826241 |
Enterprise Value/Revenue | 2.336 |
Enterprise Value/EBITDA | 667.335 |
Trading Information
Lifecore Biomedical, Inc. Stock Price History
Beta (5Y Monthly) | 1.03169 |
52-Week Change | -10.61% |
S&P500 52-Week Change | 20.43% |
52 Week High | 11.3 EUR |
52 Week Low | 1.54 EUR |
50-Day Moving Average | 4.72 EUR |
200-Day Moving Average | 6.61 EUR |
LDE.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 30.32M |
Float | 20.17M |
Short Ratio | N/A |
% Held by Insiders | 0.99% |
% Held by Institutions | 81.79% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | May 29, 2022 |
Most Recent Quarter (mrq) | February 26, 2023 |
Next Fiscal Year End | May 29, 2023 |
Profitability
Profit Margin | -57.84% |
Operating Margin (ttm) | -11.30% |
Gross Margin | 22.09% |
EBITDA Margin | 0.34% |
Management Effectiveness
Return on Assets (ttm) | -4.36% |
Return on Equity (ttm) | -64.21% |
Income Statement
Revenue (ttm) | 173.39M EUR |
Revenue Per Share (ttm) | 5.83 EUR |
Quarterly Revenue Growth (yoy) | -26.20% |
Gross Profit (ttm) | 50.37M EUR |
EBITDA | 607K EUR |
Net Income Avi to Common (ttm) | -69606000 EUR |
Diluted EPS (ttm) | -2.27 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 2.95M EUR |
Total Cash Per Share (mrq) | 0.1 EUR |
Total Debt (mrq) | 126.94M EUR |
Total Debt/Equity (mrq) | 174.56 EUR |
Current Ratio (mrq) | 2.348 |
Book Value Per Share (mrq) | 1.128 |
Cash Flow Statement
Operating Cash Flow (ttm) | -19523000 EUR |
Levered Free Cash Flow (ttm) | 7.79M EUR |
Profile of Lifecore Biomedical, Inc.
Country | Germany |
State | MN |
City | Chaska |
Address | 3515 Lyman Boulevard |
ZIP | 55318 |
Phone | 952 368 4300 |
Website | https://www.lifecore.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 689 |
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was incorporated in 1986 and is headquartered in Santa Maria, California.
Q&A For Lifecore Biomedical, Inc. Stock
What is a current LDE.F stock price?
Lifecore Biomedical, Inc. LDE.F stock price today per share is 5.4 EUR.
How to purchase Lifecore Biomedical, Inc. stock?
You can buy LDE.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lifecore Biomedical, Inc.?
The stock symbol or ticker of Lifecore Biomedical, Inc. is LDE.F.
Which industry does the Lifecore Biomedical, Inc. company belong to?
The Lifecore Biomedical, Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Lifecore Biomedical, Inc. have in circulation?
The max supply of Lifecore Biomedical, Inc. shares is 31.46M.
What is Lifecore Biomedical, Inc. Price to Earnings Ratio (PE Ratio)?
Lifecore Biomedical, Inc. PE Ratio is now.
What was Lifecore Biomedical, Inc. earnings per share over the trailing 12 months (TTM)?
Lifecore Biomedical, Inc. EPS is -1.97 EUR over the trailing 12 months.
Which sector does the Lifecore Biomedical, Inc. company belong to?
The Lifecore Biomedical, Inc. sector is Healthcare.